Table 1.
Biomaterial | Scaffold type | Cancer | Refs |
---|---|---|---|
Natural materials | |||
Silk fibroin | Scaffold, hydrogel, mat | MM, prostate, breast, osteosarcoma | 59, 60, 61, 62 |
Collagen | Hydrogel, scaffold | Breast, prostate, osteosarcoma | 63, 64, 65 |
Chitosan‐alginate | Scaffold | Prostate, glioblastoma, hepatocellular carcinoma | 66, 67 |
Hyaluronic acid | Scaffold, hydrogel | Renal cell carcinoma, MM | 68, 69 |
Bacterial nanocellulose | Scaffold, hydrogel | Neuroblastoma, osteosarcoma, prostate, renal cancer, breast | 70, 71 |
Native ECM | Scaffold | MM, breast | 72, 73 |
ECM/cartilaginous matrix/Matrigel | Scaffold, hydrogel | Breast | 74 |
Chitosan (with or without HA or collagen) | Scaffold | Breast | 75 |
Cell sheets over medical‐grade polycaprolactone‐tricalcium phosphate | scaffold | prostate | 76 |
Synthetic materials | |||
Poly(ethylene) glycol | Hydrogel | Breast, prostate | 77, 78, 79 |
Poly(ε‐caprolactone) | Hydrogel | Breast, prostate, osteosarcoma, Ewing sarcoma | 80, 81, 82 |
Poly(amino acid‐)‐based polymers | Hydrogel | Osteosarcoma | 83 |
PLG (nonmineralized) and PLG mineralized with HA | Scaffold | Breast | 84 |
Adapted with permission from Sitarski and colleagues.33
BM = bone marrow; ECM = extracellular matrix; HA = hydroxyapatite; MM = multiple myeloma; PLG = poly(lactide‐co‐glycolide).